Evidence map›Paper›PMID 24240690›Full record

ArticleOncogene2014

Ras regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.

E Zaganjor, J K Osborne, L M Weil, L A Diaz-Martinez, J X Gonzales, S M Singel, J E Larsen, L Girard, J D Minna, M H Cobb

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. The role of kinesin superfamily proteins in hepatocellular carcinoma.Medical oncology (Northwood, London, England) · 2024
    Review
  3. Article
  4. Article
  5. Down regulated oncogeneAnnals of translational medicine · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Arf GAPs and molecular motors.Small GTPases · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

E ZaganjorDepartment of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
J K OsborneDepartment of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
L M WeilDepartment of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
L A Diaz-MartinezDepartment of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
J X GonzalesDepartment of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
S M SingelDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
J E LarsenHamon Cancer Center for Therapeutic Oncology Research, Dallas, TX, USA.
L Girard1] Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA [2] Hamon Cancer Center for Therapeutic Oncology Research, Dallas, TX, USA.
J D Minna1] Department of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA [2] Hamon Cancer Center for Therapeutic Oncology Research, Dallas, TX, USA.
M H CobbDepartment of Pharmacology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
The University of Texas Southwestern Medical Center · US

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GIBBONS, DON LYNN · 1996 to 2024
$57.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
MECHANISMS OF DRUG ACTION AND DISPOSITIONT32GM007062 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI MANGELSDORF, DAVID J · 1985 to 2020
$7.4M
Insulin-Regulated MAP Kinase PathwaysR37DK034128 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 2007 to 2016
$5.1M
NCI NIH HHS P30 CA142543NCI NIH HHS P50 CA070907NCI NIH HHS P50CA70907NIDDK NIH HHS R37 DK034128NIDDK NIH HHS R37 DK34128NIGMS NIH HHS 5-T32 GM007062NIGMS NIH HHS T32 GM007062
6 · The paper itself

Abstract

We show that expression of the microtubule depolymerizing kinesin KIF2C is induced by transformation of immortalized human bronchial epithelial cells (HBEC) by expression of K-Ras(G12V) and knockdown of p53. Further investigation demonstrates that this is due to the K-Ras/ERK1/2 MAPK pathway, as loss of p53 had little effect on KIF2C expression. In addition to KIF2C, we also found that the related kinesin KIF2A is modestly upregulated in this model system; both proteins are expressed more highly in many lung cancer cell lines compared to normal tissue. As a consequence of their depolymerizing activity, these kinesins increase dynamic instability of microtubules. Depletion of either of these kinesins impairs the ability of cells transformed with mutant K-Ras to migrate and invade matrigel. However, depletion of these kinesins does not reverse the epithelial to mesenchymal transition (EMT) caused by mutant K-Ras. Our studies indicate that increased expression of microtubule destabilizing factors can occur during oncogenesis to support enhanced migration and invasion of tumor cells.

Indexed as

Cell Transformation, NeoplasticGenes, rasBronchiCarcinoma, BronchogenicCell MovementCytoskeletonEpithelial CellsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticGene Knockdown TechniquesHumansKinesinsMicrotubulesMutationSignal TransductionTumor Suppressor Protein p53KIF2A protein, humanKIF2C protein, humanKinesinsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID24240690
PMCPMC4025984
OpenAlexW2062761325

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.